Gerard Sanacora
Affiliations: | Yale University, New Haven, CT |
Area:
PsychiatryGoogle:
"Gerard Sanacora"Cross-listing: Neurotree
Collaborators
Sign in to add collaborator| Yann Mineur | collaborator | 2005- | Yale (Neurotree) |
| Christopher J. Pittenger | collaborator | 2006- | Yale (Neurotree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Krystal JH, Kaye AP, Jefferson S, et al. (2023) Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments. Proceedings of the National Academy of Sciences of the United States of America. 120: e2305772120 |
| McIntyre RS, Alsuwaidan M, Baune BT, et al. (2023) Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 22: 394-412 |
| Raison CL, Sanacora G, Woolley J, et al. (2023) Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial. Jama |
| Banasr M, Codeluppi S, Xu M, et al. (2023) Prefrontal Cortex Astroglia Modulate Anhedonia-like Behavior. Research Square |
| Anand A, Mathew SJ, Sanacora G, et al. (2023) Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. The New England Journal of Medicine |
| Zaki N, Chen LN, Lane R, et al. (2023) Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |
| Abi-Dargham A, Moeller SJ, Ali F, et al. (2023) Candidate biomarkers in psychiatric disorders: state of the field. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 22: 236-262 |
| Bansal Y, Fee C, Misquitta KA, et al. (2023) Prophylactic Efficacy of Riluzole against Anxiety- and Depressive-Like Behaviors in Two Rodent Stress Models. Complex Psychiatry. 9: 57-69 |
| Leal GC, Souza-Marques B, Mello RP, et al. (2023) Arketamine as adjunctive therapy for treatment-resistant depression: A placebo-controlled pilot study. Journal of Affective Disorders. 330: 7-15 |
| Holmes SE, Asch RH, Davis MT, et al. (2022) Differences in Quantification of the Metabotropic Glutamate Receptor 5 Across Bipolar Disorder and Major Depressive Disorder. Biological Psychiatry |